Treatment · May 13, 2026
FDA Approves First Non-Antipsychotic Drug for Agitation in Alzheimer’s
FDA approval expands treatment options available to Alzheimer's disease patients....
Research · March 19, 2026
First Down Syndrome Patient Enrolled In Landmark Alzheimer's Prevention Trial
Landmark study enrollment of Down syndrome participants expands Alzheimer's research to underrepresented populations....
Research · March 19, 2026
New Alzheimer's Research Chair Established Through Major Funding Partnership
New partnership expands Alzheimer's research capabilities and potential treatments....
Technology · March 18, 2026
Simple Nasal Swab Test Detects Early Signs of Alzheimer's Disease
A simple nasal swab test can now detect early Alzheimer's signals, enabling earlier diagnosis and intervention....
Technology · March 18, 2026
New Alzheimer's Data Platform Uses Millions of Records to Predict Disease
Innovative data platform improves prediction and understanding of Alzheimer's disease progression....
Research · March 16, 2026
New Diagnostic Methods Identify Combined Alzheimer's and FTLD Dementia
Researchers develop methods to diagnose Alzheimer's disease combined with difficult-to-identify dementia types....
Breakthrough · March 2, 2026
Alzheimer's Drug Development Emerges From Long Period Of Setbacks
Major innovation breakthrough achieved in Alzheimer's disease pharmaceutical development....
Breakthrough · December 23, 2025
Study Shows Full Neurological Recovery From Alzheimer's Is Possible in Animals
Groundbreaking research demonstrates full neurological recovery from Alzheimer's disease in animal models, not just prevention....
Breakthrough · December 4, 2025
Alzheimer's Research Reaches an Inflection Point With New Treatments
Major breakthroughs in Alzheimer's science promise exciting new treatment possibilities....